QuintilesIMS to Announce Third-Quarter 2016 Results On November 2, 2016
October 19 2016 - 4:15PM
Business Wire
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will
issue its third-quarter 2016 financial results before the market
opens on Wednesday, November 2, 2016. The earnings release and
accompanying financial information will be posted on the
QuintilesIMS Investor Relations website at
http://ir.quintilesims.com.
The QuintilesIMS management team will host a conference call and
webcast to discuss the company’s results at 9:00 a.m. Eastern Time
on November 2. Interested parties are invited to listen to the live
event and view the presentation slides via webcast on the
QuintilesIMS Investor Relations website at
http://ir.quintilesims.com. The discussion also will be available
by dialing +1-800-694-4033 in the U.S. and Canada, or
+1-303-223-4393 for international callers.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event on November 2. To
access the webcast recording, visit http://ir.quintilesims.com.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated
to helping its clients improve their clinical, scientific and
commercial results. Formed through the merger of Quintiles and IMS
Health, QuintilesIMS’s approximately 50,000 employees conduct
operations in more than 100 countries. Companies seeking to improve
real-world patient outcomes and enhanced clinical trial outsourcing
through treatment innovations, care provision and access can
leverage QuintilesIMS’s broad range of healthcare information,
technology and service solutions to drive new insights and
approaches. QuintilesIMS provides solutions that span clinical to
commercial bringing clients a unique opportunity to realize the
full potential of innovations and advance healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS
protects individual privacy while managing information to drive
healthcare forward. These insights and execution capabilities help
biotech, medical device, and pharmaceutical companies, medical
researchers, government agencies, payers and other healthcare
stakeholders in the development and approval of new therapies,
identify unmet treatment needs and understand the safety,
effectiveness and value of pharmaceutical products in improving
overall health outcomes. To learn more, visit
www.quintilesims.com/. QUINTILESIMSFIN
Click here to subscribe to Mobile Alerts for QuintilesIMS.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161019006290/en/
QuintilesTom Kinsley, Investor Relations
(thomas.kinsley@quintlesims.com)+1.203.448.4691orTodd Kasper,
Investor Relations
(todd.kasper@quintilesims.com)+1.919.998.2590orPhil Bridges,
QuintilesIMS Media Relations
(phil.bridges@quintilesims.com)+1.919.998.1653 (office)
+1.919.457.6347 (mobile)orTor Constantino, QuintilesIMS Media
Relations (tor.constantino@quintilesims.com)+1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2024 to May 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From May 2023 to May 2024